Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.64
04.02.25
-
04.03.25
-
05.03.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.64
09.12.24
-
09.01.25
-
10.01.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.64
09.12.24
-
09.01.25
-
10.01.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.64
05.12.24
-
05.01.25
0.00%
06.01.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.74
03.12.24
-
03.01.25
-1.48%
04.01.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€0.23
01.10.24
-
01.11.24
3.20%
02.11.24

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€0.31
12.08.24
-
12.09.24
-4.34%
13.09.24

Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€0.97
30.03.24
-
30.03.25
-80.53%
31.03.25

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€1.08
27.11.23
€2.00
27.11.24
-0.74%
09.12.23

positive Cash Flow expected
Good rating
Valuable balance sheet
Very capable Management
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€1.03
25.11.23
€0.000
25.11.24
4.26%
09.12.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€1.23
14.11.23
-
14.12.26
-84.64%
05.12.24

Increased challenges to pay loans and raise capital
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€2.14
11.11.23
€1.00
11.11.24
-51.78%
25.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€1.95
30.10.23
-
30.10.24
-47.23%
19.01.24

Probably not worthwhile Investment
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€3.43
16.09.23
€1.00
16.09.24
-17.66%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€4.71
13.09.23
-
13.09.24
-29.86%
15.09.23

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.38
06.02.23
-
06.02.24
-87.11%
07.02.24

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€7.31
16.10.22
-
16.10.23
-12.67%
05.02.23

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€6.88
08.10.22
€12.00
08.10.23
6.28%
16.10.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€8.93
30.08.22
€10.00
30.08.23
-68.87%
31.08.23

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€12.48
05.02.22
€24.00
05.02.23
13.78%
19.02.22

buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€13.86
31.01.22
€42.00
31.01.23
-9.96%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€23.60
22.01.22
€40.00
22.01.23
-47.12%
05.02.22

Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€24.25
17.01.22
-
17.01.23
-2.68%
23.01.22

Mainz Biomed B.v.

Start price
Target price
Perf. (%)
€16.65
05.01.22
-
05.01.23
-25.58%
09.01.22